OnabotulinumtoxinA Re-Injection for Refractory Detrusor Overactivity Using 3-4 Injection Sites
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
OnabotulinumtoxinA Re-Injection for Refractory Detrusor Overactivity Using 3-4 Injection Sites: Results of a Pilot Study
Urology 2019 Dec 17;[EPub Ahead of Print], E Martínez-Cuenca, MA Bonillo, E Morán, E Broseta, S ArlandisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.